PDMC Implementation Trial in Kenya

Recruiting Phase 4 Interventional Study
Severe Malaria Severe Anemia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
Up to 9
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Prevention
Participants needed
600 (estimated)
Sponsor
Liverpool School of Tropical Medicine · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this implementation trial is to evaluate at least two alternative delivery strategies and adherence support for malaria chemoprevention with dihydroartemisinin-piperaquine in the post-discharge management of children hospitalised with severe anaemia or severe malaria to optimise adherence in Kenya. The actual interventions to be evaluated have been co-designed with national stakeholde…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: CLUSTERS * Health facilities with blood transfusion services offering in-patient care for children with severe anaemia and severe malaria. * \>=40 children per year admitted with severe anaemia or severe malaria * Agreement to participate by facility management * Located in are…
Contacts

Jenny Hill, MSc, PhD

+44 7732 161 353

jenny.hill@lstmed.ac.uk

CONTACT

Juliet Otieno, MD, PhD

+254 721432548

Juliet.Otieno@lstmed.ac.uk

CONTACT